Fig. 4
From: ERBB3-related gene PBX1 is associated with prognosis in patients with HER2-positive breast cancer
Construction of risk models, survival status and mRNA expression levels in the training and validation set. In the training set, A-B Risk score plot (A) and survival state scatterplot (B) of HER2-positve BC patients. C Kaplan-Meier OS analysis of high- and low-risk model groups. D AUC predicting 1-, 3-, and 5-year survival in HER2-positve BC patients. E Box plots of expression levels of PBX1, IGHM, and CXCL13 genes between high- and low-risk model groups. In the validation set, F-G Risk score plot (F) and survival state scatterplot (G) of HER2-positve BC patients. H Kaplan-Meier OS analysis of high- and low-risk model groups. I AUC predicting 1-, 3-, and 5-year survival in HER2-positve BC patients. J Box plots of expression levels of PBX1, IGHM, and CXCL13 genes between high- and low-risk model groups. BC, breast cancer; OS, overall survival; AUC, area under the curve.*p < 0.05, **p < 0.01, ***p < 0.001, and “ns” represents non-significant